These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29764562)

  • 1. Osteoclast-derived SLIT3 is a coupling factor linking bone resorption to bone formation.
    Koh JM
    BMB Rep; 2018 Jun; 51(6):263-264. PubMed ID: 29764562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclast-secreted SLIT3 coordinates bone resorption and formation.
    Kim BJ; Lee YS; Lee SY; Baek WY; Choi YJ; Moon SA; Lee SH; Kim JE; Chang EJ; Kim EY; Yoon J; Kim SW; Ryu SH; Lee SK; Lorenzo JA; Ahn SH; Kim H; Lee KU; Kim GS; Koh JM
    J Clin Invest; 2018 Apr; 128(4):1429-1441. PubMed ID: 29504949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLIT2 inhibits osteoclastogenesis and bone resorption by suppression of Cdc42 activity.
    Park SJ; Lee JY; Lee SH; Koh JM; Kim BJ
    Biochem Biophys Res Commun; 2019 Jun; 514(3):868-874. PubMed ID: 31084928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opening windows for bone remodeling through a SLIT.
    Iqbal J; Yuen T; Kim SM; Zaidi M
    J Clin Invest; 2018 Apr; 128(4):1255-1257. PubMed ID: 29504950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLIT3 regulates endochondral ossification by β-catenin suppression in chondrocytes.
    Kim H; Choi YJ; Lee YS; Park SY; Baek JE; Kim HK; Kim BJ; Lee SH; Koh JM
    Biochem Biophys Res Commun; 2018 Dec; 506(4):847-853. PubMed ID: 30389141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.
    Iezaki T; Onishi Y; Ozaki K; Fukasawa K; Takahata Y; Nakamura Y; Fujikawa K; Takarada T; Yoneda Y; Yamashita Y; Shioi G; Hinoi E
    J Bone Miner Res; 2016 Mar; 31(3):573-84. PubMed ID: 26391411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of bone metabolism by Wnt signals.
    Kobayashi Y; Uehara S; Udagawa N; Takahashi N
    J Biochem; 2016 Apr; 159(4):387-92. PubMed ID: 26711238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
    Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
    Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling.
    Muguruma Y; Hozumi K; Warita H; Yahata T; Uno T; Ito M; Ando K
    J Cell Physiol; 2017 Sep; 232(9):2569-2580. PubMed ID: 27735989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
    Glass DA; Bialek P; Ahn JD; Starbuck M; Patel MS; Clevers H; Taketo MM; Long F; McMahon AP; Lang RA; Karsenty G
    Dev Cell; 2005 May; 8(5):751-64. PubMed ID: 15866165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclast-derived activity in the coupling of bone formation to resorption.
    Martin TJ; Sims NA
    Trends Mol Med; 2005 Feb; 11(2):76-81. PubMed ID: 15694870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CX3CL1/fractalkine in osteoclast differentiation and bone resorption.
    Koizumi K; Saitoh Y; Minami T; Takeno N; Tsuneyama K; Miyahara T; Nakayama T; Sakurai H; Takano Y; Nishimura M; Imai T; Yoshie O; Saiki I
    J Immunol; 2009 Dec; 183(12):7825-31. PubMed ID: 19923448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation.
    Weivoda MM; Ruan M; Pederson L; Hachfeld C; Davey RA; Zajac JD; Westendorf JJ; Khosla S; Oursler MJ
    J Bone Miner Res; 2016 Jan; 31(1):76-85. PubMed ID: 26108893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasorin as an actor of bone turnover?
    Andrique C; Bonnet AL; Dang J; Lesieur J; Krautzberger AM; Baroukh B; Torrens C; Sadoine J; Schmitt A; Rochefort GY; Bardet C; Six I; Houillier P; Tharaux PL; Schrewe H; Gaucher C; Chaussain C
    J Cell Physiol; 2024 Jun; 239(6):e31257. PubMed ID: 38504496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
    Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
    J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoprotection by semaphorin 3A.
    Hayashi M; Nakashima T; Taniguchi M; Kodama T; Kumanogoh A; Takayanagi H
    Nature; 2012 May; 485(7396):69-74. PubMed ID: 22522930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An angiogenic approach to osteoanabolic therapy targeting the SHN3-SLIT3 pathway.
    Yallowitz AR; Shim JH; Xu R; Greenblatt MB
    Bone; 2023 Jul; 172():116761. PubMed ID: 37030497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.